Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ´ç´¢º´ > Strategic Analysis of the South African Diabetes Markets
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

Strategic Analysis of the South African Diabetes Markets

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 04¿ù »óǰÄÚµå 64709
ÆäÀÌÁö Á¤º¸ 144 Pages
°¡°Ý
US $ 7,500 £Ü 8,936,200 Web Access (Regional License)
US $ 8,000 £Ü 9,532,000 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This Frost & Sullivan research service titled Strategic Analysis of the South African Diabetes Markets provides an overview of the South African healthcare industry in the context of diabetes treatment drugs as divided between Type 1 and Type 2 diabetics. In this research, Frost & Sullivan' s expert analysts thoroughly examine key industry challenges, drivers, restraints, and trends. Revenue forecasts and strategic recommendations are also provided.

This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

  • 1. Executive Summary
  • 2. Research Objectives, Scope and Methodology
  • 3. Strategic Analysis of the South African Diabetes Markets
  • 4. List of Key Industry Participants
  • 5. Decision Support Databases
Back to Top